BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 11/04/2024

FDA Clears VISTARIL Oral Suspension for Approval

The FDA has determined that VISTARIL Oral Suspension, 25mg/5mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.

Source: Federal Register — Food and Drug AdministrationOpen original release →